Location History:
- Frederick, MD (US) (2009)
- Pittsburgh, PA (US) (2014 - 2015)
- Reston, VA (US) (2013 - 2021)
Company Filing History:
4 out of 1,863 
3 out of 3,539 
2 out of 1,929 
Years Active: 2009-2021
Title: Thomas P. Conrads: A Pioneer in Antiproliferative Research
Introduction
Thomas P. Conrads is an accomplished inventor based in Frederick, MD, USA. With a notable portfolio of three patents, he has made significant contributions to the field of medical research, particularly in understanding and combating cancer and other related diseases. His latest innovations focus on the development of novel antiproliferative factors that have the potential to change how interstitial cystitis and cancer are treated.
Latest Patents
One of Thomas P. Conrads' most recent patents is titled "Antiproliferative Factor and Methods of Use," which discloses a groundbreaking glycopeptide associated with the bladder. This novel discovery includes compositions, diagnostic kits, and reagents, outlining methods for identifying and treating conditions such as interstitial cystitis and cancer. The implications of this research are profound, as it opens new avenues for therapeutic interventions in medical science.
Career Highlights
Throughout his career, Thomas P. Conrads has worked with prestigious organizations that have furthered his research and innovations. Notably, he has been affiliated with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, and the University System of Maryland. These institutions have provided him with a platform to advance crucial research that benefits public health.
Collaborations
Conrads has also collaborated with notable professionals in his field, including Timothy D. Veenstra and Susan K. Keay. These partnerships have enriched his work, fostering an environment of innovation and shared knowledge that is critical in scientific research and development.
Conclusion
Thomas P. Conrads stands out as a significant figure in the landscape of medical inventions. His dedication to research and development of antiproliferative factors marks a vital step forward in the treatment of serious medical conditions. As he continues to innovate, the impact of his work is sure to resonate in both the scientific community and the lives of patients worldwide.